Penn Davis Mcfarland Inc Gilead Sciences, Inc. Transaction History

Penn Davis Mcfarland Inc

$849 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$57.72 - $65.01 $1.49 Million - $1.68 Million	-25,787 Reduced 8.8%	267,243 $16.5 Million
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $36,952 - $46,306	-638 Reduced 0.22%	293,030 $17.4 Million
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $957,563 - $1.09 Million	14,759 Added 5.29%	293,668 $21.3 Million
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $92,058 - $99,320	1,360 Added 0.49%	278,909 $19.5 Million
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $488,528 - $533,786	7,697 Added 2.85%	277,549 $19.1 Million
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $106,200 - $121,174	1,770 Added 0.66%	269,852 $17.4 Million
Q4 2020 Jan 22, 2021	BUY	$56.65 - $64.55 $1 Million - $1.14 Million	17,672 Added 7.06%	268,082 $15.6 Million
Q3 2020 Oct 28, 2020	BUY	$62.1 - $78.08 $127,801 - $160,688	2,058 Added 0.83%	250,410 $15.8 Million
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $50,203 - $58,296	-694 Reduced 0.28%	248,352 $19.1 Million
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $11.2 Million - $14.4 Million	179,572 Added 258.47%	249,046 $18.6 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $7.17 Million - $7.89 Million	-116,417 Reduced 62.63%	69,474 $4.51 Million
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $19,253 - $21,252	308 Added 0.17%	185,891 $11.8 Million
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $13,302 - $14,916	215 Added 0.12%	185,583 $12.5 Million
Q1 2019 Apr 25, 2019	BUY	$62.53 - $70.05 $411,885 - $461,419	6,587 Added 3.68%	185,368 $12.1 Million
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $57,876 - $75,524	-956 Reduced 0.53%	178,781 $11.2 Million
Q3 2018 Oct 24, 2018	BUY	$71.28 - $78.92 $63,225 - $70,002	887 Added 0.5%	179,737 $13.9 Million
Q2 2018 Jul 20, 2018	BUY	$64.88 - $75.68 $711,668 - $830,133	10,969 Added 6.53%	178,850 $12.7 Million
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $23,745 - $28,948	326 Added 0.19%	167,881 $12.7 Million
Q4 2017 Jan 18, 2018	SELL	$71.15 - $83.52 $241,838 - $283,884	-3,399 Reduced 1.99%	167,555 $12 Million
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $12.3 Million - $14.6 Million	170,954	170,954 $13.9 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Davis Mcfarland Inc, based on Form 13F filings with the SEC.

News

Stay updated on Penn Davis Mcfarland Inc with notifications on news.

Account